Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

190 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Levodopa therapeutics for Parkinson's disease: new developments.
LeWitt PA. LeWitt PA. Parkinsonism Relat Disord. 2009 Jan;15 Suppl 1:S31-4. doi: 10.1016/S1353-8020(09)70009-4. Parkinsonism Relat Disord. 2009. PMID: 19131040 Review.
Ceruloplasmin is increased in cerebrospinal fluid in Alzheimer's disease but not Parkinson's disease.
Loeffler DA, DeMaggio AJ, Juneau PL, Brickman CM, Mashour GA, Finkelman JH, Pomara N, LeWitt PA. Loeffler DA, et al. Among authors: lewitt pa. Alzheimer Dis Assoc Disord. 1994 Fall;8(3):190-7. doi: 10.1097/00002093-199408030-00005. Alzheimer Dis Assoc Disord. 1994. PMID: 7986488
Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis.
LeWitt PA, Verhagen Metman L, Rubens R, Khanna S, Kell S, Gupta S. LeWitt PA, et al. Clin Neuropharmacol. 2018 Mar/Apr;41(2):47-55. doi: 10.1097/WNF.0000000000000269. Clin Neuropharmacol. 2018. PMID: 29432286 Free PMC article. Clinical Trial.
Recent advances in CSF biomarkers for Parkinson's disease.
LeWitt P. LeWitt P. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S49-51. doi: 10.1016/S1353-8020(11)70017-7. Parkinsonism Relat Disord. 2012. PMID: 22166453 Review.
Comparison of dysphagia before and after deep brain stimulation in Parkinson's disease.
Silbergleit AK, LeWitt P, Junn F, Schultz LR, Collins D, Beardsley T, Hubert M, Trosch R, Schwalb JM. Silbergleit AK, et al. Among authors: lewitt p. Mov Disord. 2012 Dec;27(14):1763-8. doi: 10.1002/mds.25259. Epub 2012 Oct 31. Mov Disord. 2012. PMID: 23115021
Intraoperative MRI for deep brain stimulation lead placement in Parkinson's disease: 1 year motor and neuropsychological outcomes.
Sidiropoulos C, Rammo R, Merker B, Mahajan A, LeWitt P, Kaminski P, Womble M, Zec A, Taylor D, Wall J, Schwalb JM. Sidiropoulos C, et al. Among authors: lewitt p. J Neurol. 2016 Jun;263(6):1226-31. doi: 10.1007/s00415-016-8125-0. Epub 2016 Apr 28. J Neurol. 2016. PMID: 27126457
Nighttime Sleep and Daytime Sleepiness Improved With Pimavanserin During Treatment of Parkinson's Disease Psychosis.
Patel N, LeWitt P, Neikrug AB, Kesslak P, Coate B, Ancoli-Israel S. Patel N, et al. Among authors: lewitt p. Clin Neuropharmacol. 2018 Nov/Dec;41(6):210-215. doi: 10.1097/WNF.0000000000000307. Clin Neuropharmacol. 2018. PMID: 30303817 Review.
Caloric vestibular stimulation for the management of motor and non-motor symptoms in Parkinson's disease.
Wilkinson D, Podlewska A, Banducci SE, Pellat-Higgins T, Slade M, Bodani M, Sakel M, Smith L, LeWitt P, Ade KK. Wilkinson D, et al. Among authors: lewitt p. Parkinsonism Relat Disord. 2019 Aug;65:261-266. doi: 10.1016/j.parkreldis.2019.05.031. Epub 2019 May 31. Parkinsonism Relat Disord. 2019. PMID: 31300264 Clinical Trial.
Levodopa in the treatment of Parkinson's disease: current controversies.
Olanow CW, Agid Y, Mizuno Y, Albanese A, Bonuccelli U, Damier P, De Yebenes J, Gershanik O, Guttman M, Grandas F, Hallett M, Hornykiewicz O, Jenner P, Katzenschlager R, Langston WJ, LeWitt P, Melamed E, Mena MA, Michel PP, Mytilineou C, Obeso JA, Poewe W, Quinn N, Raisman-Vozari R, Rajput AH, Rascol O, Sampaio C, Stocchi F. Olanow CW, et al. Among authors: lewitt p. Mov Disord. 2004 Sep;19(9):997-1005. doi: 10.1002/mds.20243. Mov Disord. 2004. PMID: 15372588 Review.
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
Shoulson I, Oakes D, Fahn S, Lang A, Langston JW, LeWitt P, Olanow CW, Penney JB, Tanner C, Kieburtz K, Rudolph A; Parkinson Study Group. Shoulson I, et al. Among authors: lewitt p. Ann Neurol. 2002 May;51(5):604-12. doi: 10.1002/ana.10191. Ann Neurol. 2002. PMID: 12112107 Clinical Trial.
190 results
Jump to page
Feedback